期刊
MATURITAS
卷 67, 期 1, 页码 46-53出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.maturitas.2010.04.017
关键词
Serum tumour markers; Ovarian cancer; Endometrial cancer; CA125; Cervical cancer
Serum tumour markers have had a role in screening, diagnosis and monitoring of some gynaecological cancers. Women with suspected ovarian malignancies have as routine a CA125 serum test, and in conjunction with scans, the risk of malignancy can be calculated. Equally, this CA125, if elevated pre-operatively can be used to predict chemotherapeutic responses, and even disease relapse prior to any symptoms or clinical findings. Other useful markers in ovarian cancer are beta HCG and AFP produced by germ cell tumours. beta HCG is also of extreme importance in both the diagnosis and management of choriocarcinomas. The level of beta HCG determines the need, and with other indicators, the type of chemotherapeutic intervention. Other serum markers are known in cervical cancer, and possibly endometrial and vulval cancer-but their clinical utility is very limited. Novel markers may help in managing patients, and in the future permit screening for certain diseases. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据